Intra-Cellular Therapies Competitors and Similar CompaniesClear all
Intra-Cellular Therapies's competitors and similar companies include Supernus Pharmaceuticals, Lutonix, Histocell and Neofluidics.
 Intra-Cellular Therapies Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS. |  Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. |  Lutonix Lutonix DCB is a new drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation. |  Histocell Histocell is a biopharmaceutical company focused on the development, manufacturing, and commercialization of medical devices, active ingredients, and cell therapy drugs for regenerative medicine. | ||
Founding Date | Founding Date 2002 | Founding Date 2005 | Founding Date 2007 | Founding Date 2011 | Founding Date 2014 |
Type | Type Public | Type Public | Type Subsidiary | Type Private | Type Private |
Tags | |||||
Locations | Locations New York, US HQ | Locations Rockville, US HQ | Locations Maple Grove, US HQ | Locations Derio, ES HQ Larrabetzu, ES | Locations San Diego, US HQ Lubbock, US |
Employees | Employees 330352% increase | Employees 6527% increase | Employees 10 | Employees 365% decrease | Employees 3 |
Valuation ($) | Valuation ($) 8.1 b | Valuation ($) 1.9 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $680.9m (FY, 2024) | Revenue (est.) $719m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($74.7m) (FY, 2024) | Net income ($38.6m) (FY, 2025) | Net income N/A | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 225.3m | Total funding raised $ 69.5m | Total funding raised $ 35m | Total funding raised N/A | Total funding raised $ 3.2m |
For sources of this data, please see the company profile
View Company Profiles
Supernus Pharmaceuticals
HQ
Rockville, US
Employees
652↑ 7% increase
Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.
View companyLutonix
HQ
Maple Grove, US
Lutonix DCB is a new drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation.
View companyHistocell
HQ
Derio, ES
Employees
36↓ 5% decrease
Histocell is a biopharmaceutical company focused on the development, manufacturing, and commercialization of medical devices, active ingredients, and cell therapy drugs for regenerative medicine.
View company
Neofluidics
HQ
San Diego, US
Employees
3
Neofluidics is a company that develops tools and technology for enhanced microfluidics.
View company